Dmitry Balyasny’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Dmitry Balyasny’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-539,793	Closed	-$33.6M	–	3253
2023 Q4	$33.6M	Buy	+539,793	New	+$13.4M	0.06%	398

Dmitry Balyasny's RYZB Position: Q1 2024 in Review

Dmitry Balyasny sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 539,793 shares — an estimated $33.6M sold.

Dmitry Balyasny first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $33.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Dmitry Balyasny reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Dmitry Balyasny sold 539,793 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $33.6M.
Dmitry Balyasny first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Dmitry Balyasny's RayzeBio, Inc. Common Stock position peaked at $33.6M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.